obesity

Vivus Tumbles On Extended FDA Review
Barron's
Tue, 04/10/12 - 11:08 am
FDA
Vivus
Qnexa
obesity
FDA will take 3 more months to review Vivus drug
Yahoo/AP
Mon, 04/9/12 - 05:43 pm
Vivus
FDA
Qnexa
obesity
Vivus: Ready To Gain From Qnexa
Seeking Alpha
Mon, 04/9/12 - 11:57 am
Vivus
Qnexa
obesity
JNJ
Novartis
Pfizer
Teva Pharmaceuticals
Arena: Which Way, Up Or Down?
Seeking Alpha
Thu, 04/5/12 - 08:41 am
Arena
obesity
lorcaserin
3 Anti-Obesity Drug Companies Poised To Grow
Seeking Alpha
Tue, 04/3/12 - 08:59 am
obesity
Vivus
Orexigen
lorcaserin
Arena Pharmaceuticals
Contrave
Qnexa
Obesity startup Obalon pulls in $1.5M
Mon, 04/2/12 - 11:01 pm
obesity
Obalon
funding
Sector Snap: Obesity drug companies
Yahoo/AP
Sat, 03/31/12 - 11:49 am
Orexigen
Vivus
lorcaserin
Qnexa
Arena Pharmaceuticals
Contrave
obesity
Vivus, Arena Unlikely to Be Affected by FDA Obesity Panel
Bloomberg
Fri, 03/30/12 - 12:00 pm
Arena
Vivus
FDA
obesity
advisory panels
Orexigen
Panel Recommends More Testing for Obesity Drugs
NY Times, NY
Fri, 03/30/12 - 11:11 am
obesity
FDA
advisory panels
Weight loss: FDA weighs obesity devices
Thu, 03/29/12 - 11:06 pm
FDA
obesity
Arena Pharma says EU is reviewing weight loss drug
Yahoo/AP
Mon, 03/26/12 - 12:42 pm
Arena
lorcaserin
Europe
obesity
Obesity Drugs May Need Heart Risk Studies Before Approval
Bloomberg
Mon, 03/26/12 - 12:22 pm
obesity
Vivus
Arena Pharmaceuticals
Orexigen
Qnexa
Obesity Drug Candidates' Parallels With Approval Process Of Other Drugs
Seeking Alpha
Fri, 03/23/12 - 12:18 pm
obesity
Orexigen
Arena
Avanir
Dendreon
FDA
Obesity And The FDA: Why Qnexa Is Generating Buzz
Seeking Alpha
Thu, 03/22/12 - 05:35 pm
FDA
obesity
Qnexa
Amylin Pharmaceuticals Pulling Ahead Of Roche In Anti-Obesity Drugs?
Seeking Alpha
Mon, 03/19/12 - 10:47 am
Roche
obesity
Amylin
diabetes
Xenical
Orlistat
metreleptin
Alli
Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug
Seeking Alpha
Wed, 02/29/12 - 11:04 am
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
obesity
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wed, 02/29/12 - 10:12 am
obesity
M&A
Vivus
Qnexa
JNJ
Merck
Bristol-Myers Squibb
Arena Pharmaceuticals
Orexigen
Vivus's Qnexa And Its Potential Value
Seeking Alpha
Sat, 02/25/12 - 09:23 am
Vivus
Qnexa
obesity
weight loss
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
Seeking Alpha
Fri, 02/24/12 - 09:59 am
Qnexa
Vivus
obesity
Arena Pharmaceuticals
Orexigen
Vivus rockets 99% on FDA nod
Marketwatch
Thu, 02/23/12 - 10:41 am
FDA
Vivus
obesity
Qnexa

Pages